Sanjeev Sethi is the Chief Operating Officer (COO) of Viatris. In his career spanning over three decades, he has held key leadership positions in the pharmaceutical industry leading critical functions such as Manufacturing Operations, R&D and Regulatory Affairs. At Viatris, Sanjeev leads all the Global Operations and Scientific Affairs functions.
Before this, Sanjeev was the Chief Scientific Officer of Mylan, leading the company’s Scientific Affairs functions including R&D, Regulatory Sciences, Medical and Product Safety and Risk Management. In this role, Sanjeev was also heading the Global Launch Management Group and overseeing new product launches globally.
Previously, Sanjeev was the Head of Global Injectable Operations at Mylan, where he led the operational execution for all injectable products in the portfolio. During his time with Mylan, he held other senior roles such as Head of Global Scientific Affairs and Head of Global Generics R&D.
Sanjeev joined Mylan in 2007 through the acquisition of Matrix Laboratories Limited, where he served as the Senior Vice President and Head of Finished Dose Technical Operations. Before joining Matrix, Sanjeev worked with Sandoz GmbH as the Deputy Head of Development and Registration and as Associate Director of R&D and Regulatory Affairs for Ranbaxy Research Laboratories. Sanjeev earned his master’s degree in Pharmaceutical Sciences from the Punjab University and has 40 international patents to his credit.